JP2011524352A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011524352A5 JP2011524352A5 JP2011513001A JP2011513001A JP2011524352A5 JP 2011524352 A5 JP2011524352 A5 JP 2011524352A5 JP 2011513001 A JP2011513001 A JP 2011513001A JP 2011513001 A JP2011513001 A JP 2011513001A JP 2011524352 A5 JP2011524352 A5 JP 2011524352A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- composition according
- alkyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 4
- 206010036030 Polyarthritis Diseases 0.000 claims 3
- 208000037976 chronic inflammation Diseases 0.000 claims 3
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 208000030090 Acute Disease Diseases 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 239000003981 vehicle Substances 0.000 claims 2
- 206010040047 Sepsis Diseases 0.000 claims 1
- 206010040070 Septic Shock Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08380177A EP2135864A1 (en) | 2008-06-16 | 2008-06-16 | 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
| US12/139,661 | 2008-06-16 | ||
| US12/139,661 US7781594B2 (en) | 2008-06-16 | 2008-06-16 | 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
| EP08380177.9 | 2008-06-16 | ||
| PCT/EP2009/057324 WO2009153226A1 (en) | 2008-06-16 | 2009-06-15 | 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011524352A JP2011524352A (ja) | 2011-09-01 |
| JP2011524352A5 true JP2011524352A5 (https=) | 2014-01-30 |
Family
ID=43414178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011513001A Pending JP2011524352A (ja) | 2008-06-16 | 2009-06-15 | 急性および慢性炎症性疾患治療用５−（４−メタンスルホニル−フェニル）−チアゾール誘導体 |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP2313382A1 (https=) |
| JP (1) | JP2011524352A (https=) |
| KR (1) | KR20110022679A (https=) |
| CN (1) | CN102083806A (https=) |
| AR (1) | AR072113A1 (https=) |
| AU (1) | AU2009259451B2 (https=) |
| BR (1) | BRPI0915325A2 (https=) |
| CA (1) | CA2728139A1 (https=) |
| CO (1) | CO6331429A2 (https=) |
| IL (1) | IL209801A0 (https=) |
| MA (1) | MA32473B1 (https=) |
| MX (1) | MX2010013978A (https=) |
| NZ (1) | NZ589894A (https=) |
| RU (1) | RU2495031C2 (https=) |
| SA (1) | SA109300384B1 (https=) |
| TW (1) | TWI403506B (https=) |
| UY (1) | UY31896A (https=) |
| WO (1) | WO2009153226A1 (https=) |
| ZA (1) | ZA201008877B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2961695B1 (fr) * | 2010-06-29 | 2012-07-06 | Galderma Res & Dev | Utilisation de composes dans le traitement ou la prevention de troubles cutanes |
| RU2502513C2 (ru) * | 2012-01-11 | 2013-12-27 | Государственное бюджетное учреждение здравоохранения Свердловской области "Свердловский областной клинический психоневрологический госпиталь для ветеранов войн" (ГБУЗ СО "СОКП Госпиталь для ветеранов войн") | Способ лечения больных с полиорганной патологией озонотерапией |
| CN111343975A (zh) * | 2017-11-23 | 2020-06-26 | 埃慕尼克股份公司 | 用于预防或治疗慢性炎性疾病和/或自身免疫疾病的维多地莫的剂量方案 |
| KR102076936B1 (ko) * | 2019-08-12 | 2020-02-13 | 연세대학교 산학협력단 | 티아졸 또는 이의 염을 유효성분으로 포함하는 알러지성 질환 또는 아토피 피부염 예방 또는 치료용 조성물 |
| IT202000008125A1 (it) * | 2020-04-16 | 2021-10-16 | Minerva Srl | Acidi carbossilici 3-aza-biciclo[3.2.1]ottani e loro derivati per l’uso nel trattamento di infiammazioni |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2046628A1 (en) * | 1989-02-08 | 1990-08-09 | Dee W. Brooks | 4-hydroxythiazoles as 5-lipoxygenase inhibitors |
| EP0772606A1 (en) * | 1994-07-27 | 1997-05-14 | G.D. SEARLE & CO. | Substituted thiazoles for the treatment of inflammation |
| DE69635048T2 (de) * | 1995-06-12 | 2006-02-16 | G.D. Searle & Co. | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
| AU7559200A (en) * | 1999-10-12 | 2001-04-23 | Japan Tobacco Inc. | Hypertriglyceridemia remedies and antiobestics |
| IL160327A0 (en) * | 2001-08-13 | 2004-07-25 | Janssen Pharmaceutica Nv | 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| US20050026902A1 (en) * | 2003-01-31 | 2005-02-03 | Timothy Maziasz | Methods and compositions for the treatment or prevention of human immunodeficiency virus and related conditions using cyclooxygenase-2 selective inhibitors and antiviral agents |
-
2009
- 2009-06-06 TW TW098118927A patent/TWI403506B/zh not_active IP Right Cessation
- 2009-06-12 AR ARP090102121A patent/AR072113A1/es unknown
- 2009-06-12 UY UY0001031896A patent/UY31896A/es not_active Application Discontinuation
- 2009-06-15 RU RU2011101439/04A patent/RU2495031C2/ru not_active IP Right Cessation
- 2009-06-15 CN CN2009801226820A patent/CN102083806A/zh active Pending
- 2009-06-15 KR KR1020117001228A patent/KR20110022679A/ko not_active Ceased
- 2009-06-15 BR BRPI0915325A patent/BRPI0915325A2/pt not_active IP Right Cessation
- 2009-06-15 EP EP09765806A patent/EP2313382A1/en not_active Withdrawn
- 2009-06-15 AU AU2009259451A patent/AU2009259451B2/en not_active Ceased
- 2009-06-15 CA CA2728139A patent/CA2728139A1/en not_active Abandoned
- 2009-06-15 MX MX2010013978A patent/MX2010013978A/es active IP Right Grant
- 2009-06-15 WO PCT/EP2009/057324 patent/WO2009153226A1/en not_active Ceased
- 2009-06-15 JP JP2011513001A patent/JP2011524352A/ja active Pending
- 2009-06-15 NZ NZ589894A patent/NZ589894A/en not_active IP Right Cessation
- 2009-06-15 SA SA109300384A patent/SA109300384B1/ar unknown
-
2010
- 2010-12-06 IL IL209801A patent/IL209801A0/en unknown
- 2010-12-09 ZA ZA2010/08877A patent/ZA201008877B/en unknown
-
2011
- 2011-01-13 MA MA33516A patent/MA32473B1/fr unknown
- 2011-01-14 CO CO11003796A patent/CO6331429A2/es active IP Right Grant